http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101907251-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
filingDate | 2016-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101907251-B1 |
titleOfInvention | Biomarker for diagnosis and treatment of antiestrogen-resistant or triple negative breast cancer and composition comprising the same |
abstract | The present invention relates to a novel biomarker for diagnosis and treatment of antihormonal resistance and triple-negative breast cancer, and a composition comprising the same. More particularly, the present invention relates to a novel biomarker and a composition comprising the same, Hormone therapy in anti-hormone-refractory breast cancer including triple-negative breast cancer by allowing the effective diagnosis of anti-hormone and triple-negative breast cancer and further increasing expression of Mel-18 gene or administration of Mel-18 protein The present invention can provide a pharmaceutical composition capable of dramatically improving the therapeutic efficacy of the present invention. |
priorityDate | 2015-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1007.